Elicio TherapeuticsELTX
13F holders, Q2 2026 (June 30)48holders +1
24new positions
23sold out
$3.91avg. 13F price*
At the end of Q2 2026, 48 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, up 1 from Q1 2026. 24 opened new positions and 23 sold out. The largest holders were Knoll Capital Management, LLC ($4.7M), BlackRock, Inc. ($3.0M) and Vanguard Capital Management LLC ($2.2M).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $1.9M |
| Exits | 23 | $10.2M |
All 13F filers, Q1 2026 → Q2 2026: 2,249,976 shares bought and 969,967 shares sold, net +1,280,009 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Knoll Capital Management, LLC | 2.21% | Add +92.1% | 1,211,957 | $4.7M |
| BlackRock, Inc. | 0.00% | Add +1413.9% | 766,005 | $3.0M |
| Vanguard Capital Management LLC | 0.00% | Add +10.3% | 572,151 | $2.2M |
| Geode Capital Management, LLC | 0.00% | Add +130.3% | 311,354 | $1.2M |
| State Street Corp. | 0.00% | Add +254.4% | 179,420 | $702K |
| Northern Trust Corp. | 0.00% | Add +117.9% | 130,162 | $509K |
| Ikarian Capital, LLC | 0.06% | New | 100,000 | $391K |
| Vanguard Portfolio Management LLC | 0.00% | New | 88,905 | $348K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +27.3% | 88,062 | $344K |
| Alliancebernstein L.P. | 0.00% | New | 81,280 | $318K |
| UBS Group AG | 0.00% | Add +19.7% | 40,419 | $158K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 31,706 | $124K |
| Boothbay Fund Management, LLC | 0.00% | New | 30,690 | $120K |
| Morgan Stanley | 0.00% | Reduce -21.2% | 25,546 | $100K |
| Leonteq Securities AG | 0.00% | New | 20,000 | $78K |
| Nuveen, LLC | 0.00% | New | 17,888 | $70K |
| Citigroup Inc. | 0.00% | New | 17,726 | $69K |
| Bank of New York Mellon Corp | 0.00% | New | 15,884 | $62K |
| New York State Common Retirement Fund | 0.00% | New | 14,200 | $56K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $54K |
| HighTower Advisors, LLC | 0.00% | Add +22.4% | 13,666 | $53K |
| Raymond James Financial Inc. | 0.00% | Add +14.6% | 12,720 | $50K |
| Deutsche Bank AG | 0.00% | New | 12,652 | $49K |
| Wells Fargo & Company | 0.00% | New | 11,823 | $46K |
| T. Rowe Price Associates Inc. | 0.00% | New | 10,586 | $42K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 11,972 | $42K |
| HB Wealth Management, LLC | 0.00% | No change | 10,463 | $41K |
| Summit Financial, LLC | 0.00% | Reduce -0.1% | 10,005 | $39K |
| Mayflower Financial Advisors, LLC | 0.00% | No change | 10,000 | $39K |
| Moody LYNN Lieberson & Walker, LLC | 0.00% | No change | 10,000 | $39K |
| &partners | 0.00% | No change | 10,000 | $39K |
| Rhumbline Advisers | 0.00% | New | 6,681 | $26K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 5,967 | $23K |
| JPMorgan Chase & Co. | 0.00% | New | 5,372 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +528500.0% | 5,286 | $21K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 4,416 | $17K |
| BNP Paribas Financial Markets | 0.00% | Reduce -67.3% | 2,072 | $8K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,023 | $8K |
| Barclays PLC | 0.00% | New | 1,776 | $7K |
| Legal & General Group Plc | 0.00% | New | 1,333 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,176 | $5K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,033 | $4K |
| Farther Finance Advisors, LLC | 0.00% | Add +31.4% | 947 | $4K |
| Royal Bank of Canada | 0.00% | Add +1826.1% | 443 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +123.2% | 183 | $716 |
| FMR LLC | 0.00% | New | 124 | $485 |
| National Bank of Canada | 0.00% | New | 100 | $391 |
| Sterling Capital Management LLC | 0.00% | New | 46 | $180 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.